News

Truvada ruling could allow cheap HIV prevention in the UK

https://pharmaphorum.com/news/truvada-ruling-could-allow-cheap-hiv-prevention-in-the-uk/

NICE rejects Novartis’ CAR-T in adult lymphoma

https://pharmaphorum.com/news/nice-rejects-novartis-car-t-in-adult-leukaemia/

Sanofi unveils eczema drug data, as regulators mull label expansion

https://pharmaphorum.com/news/sanofi-unveils-eczema-drug-data-as-regulators-mull-label-expansion/

FDA approves Teva’s migraine drug, decision due on Lilly’s rival

https://pharmaphorum.com/news/fda-approves-tevas-migraine-drug-decision-due-on-lillys-rival/

UK ‘less interesting’ to pharma because of Brexit – Roche CEO

https://pharmaphorum.com/news/uk-less-interesting-to-pharma-because-of-brexit-roche-ceo/

Roche calls for talks after NICE rejects drug for progressive MS

https://pharmaphorum.com/news/roche-calls-for-talks-after-nice-rejects-ocrevus/

Biosimilars underused in rheumatoid arthritis on the NHS – experts

https://pharmaphorum.com/news/biosimilars-underused-rheumatoid-arthritis-nhs-experts/

NICE backs funding for Kyowa Kirin’s bone disorder drug

https://pharmaphorum.com/news/nice-backs-funding-for-kyowa-kirins-bone-disorder-drug/

NHS to fund Novartis’ CAR-T therapy Kymriah

https://pharmaphorum.com/news/nhs-to-fund-novartis-car-t-therapy-kymriah/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search